Subscribe To
Are (more) big gains ahead for this small cap biotech stock?
A year removed from its $20 IPO of April 2021, Biomea Fusion, Inc. NASDAQ: BMEA faded into penny stock land as investors lost their appetite for high-...
June 28, 2023, 8:57 am
Promising small biotech amphastar sees actionable pullback
Amphastar Pharmaceuticals Inc. NASDAQ: AMPH, a small cap that's one of the leading performers within the biote...
June 28, 2023, 8:36 am
2 under-the-radar biotech stocks to buy in 2023
Axsome Therapeutics' exciting pipeline promises a bright future for the company. CRISPR Therapeutics is on the verge of what could be the first of man...
June 28, 2023, 7:45 am
Longeveron files registration statement for rights offering
MIAMI, June 27, 2023 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company d...
June 27, 2023, 10:07 pm
Why moonlake immunotherapeutics was such a healthy stock today
Several analysts dramatically increased their price targets on the biotech. This followed very strong clinical trial results for an investigational tr...
June 27, 2023, 6:56 pm
Psychedelic clinical trials: a glimpse at hotly-anticipated upcoming results
As part of the renewed interest in the potential health applications of psychedelics in recent years, companies ranging from biotechnology startups t...
June 27, 2023, 4:01 pm
Ac immune's stock soars 13% after fda grants fast-track designation to alzheimer's treatment
AC Immune SA's stock ACIU, +4.21% soared 13% premarket Tuesday, after the Swiss-based biotech said it h...
June 27, 2023, 7:52 am
Molecular partners to present on its radio darpin therapy (rdt) platform at snmmi 2023
RDT platform offers unique approach for tailored delivery of radioactive payloads to solid tumors RDT platform is focused on improving both tumor-targ...
June 27, 2023, 5:00 am
Molecular partners to present on its radio darpin therapy (rdt) platform at snmmi 2023
RDT platform offers unique approach for tailored delivery of radioactive payloads to solid tumors RDT platform is focused on improving both tumor-targ...
June 27, 2023, 1:00 am
Why shares of structure therapeutics rose monday
The clinical-stage biotech's lead therapy is designed to treat diabetes and obesity. Structure has enough cash, it said, to fund operations through 20...
June 26, 2023, 9:05 pm
Danaher (dhr) shares decline 10% ytd: what's pulling it down?
Lower demand for COVID-19 testing, vaccine and therapeutics within the Biotechnology and Diagnostics segments weigh on Danaher (DHR)....
June 26, 2023, 12:46 pm
Biora therapeutics presents data on the biojet™ systemic oral delivery platform at the american diabetes association 83rd scientific sessions
An average bioavailability of 37% for a GLP-1 receptor agonist was achieved in animals SAN DIEGO, June 26, 2023 (GLOBE NEWSWIRE) — Biora Therapeutic...
June 26, 2023, 10:00 am
Lucid stock moved into the fast lane, but this nasdaq biotech was monday's big winner
Nasdaq futures indicated a flat opening on Monday. Lucid Group stock climbed after announcing a strategic partnership with Aston Martin....
June 26, 2023, 9:01 am
Immunogen stock continues to defy gravity on phase 2 trials
ImmunoGen Inc. NASDAQ: IMGN is a commercial-stage biotechnology company leading in antibody-drug conjugates (ADC). ADCs are like heat-seeking missiles...
June 26, 2023, 8:13 am
Vir biotechnology presents new data evaluating the potential for vir-2218 and vir-3434 as therapies for chronic hepatitis b and hepatitis d
– Data from two ongoing clinical trials in people living with chronic hepatitis B infection suggest the combination of an antiviral with an immunomo...
June 24, 2023, 9:30 am
Ipo report: sagimet biosciences gives going public a second chance under new ceo
biotech drug developer Sagimet Biosciences is taking another shot at going public, according to a filin...
June 23, 2023, 11:52 pm
Xoma added to the russell 2000® and russell 3000® indexes
EMERYVILLE, Calif., June 23, 2023 (GLOBE NEWSWIRE) — XOMA Corporation (NASDAQ: XOMA), the biotech roy...
June 23, 2023, 10:14 pm
: sagimet biosciences gives going public a second chance under new ceo
biotech drug developer Sagimet Biosciences is giving it another shot to take itself public, according t...
June 23, 2023, 9:59 pm
Pliant therapeutics presents data from its bexotegrast program at the european association for the study of the liver (easl) international liver congress™
Presentations highlight preclinical and clinical advancements of bexotegrast program in primary sclerosing cholangitis SOUTH SAN FRANCISCO, Calif., Ju...
June 23, 2023, 11:30 am
Fda issues guidance on psychedelic drug clinical trials
The U.S. Food and Drug Administration on Friday issued its first draft guidance on psychedelic drug clinical trials, outlining considerations for comp...
June 23, 2023, 11:14 am